Skip to search formSkip to main contentSkip to account menu

Lercanidipine hydrochloride

Known as: 3,5-Pyridinedicarboxylic Acid, 1,4-Dihydro-2,6-Dimethyl-4-(3-Nitrophenyl)-, 2-((3,3-Diphenylpropyl)Methylamino)-1,1-Dimethylethyl Methyl Ester, Monohydrochloride, lercanidipine hcl 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A HPTLC method was developed and validated for determination of Lercanidipine hydrochloride in tablet formulation and in… 
2016
2016
Lercanidipine hydrochloride is a calcium channel blocker of the dihydropyridine, which opens the blood vessels for allowing the… 
2016
2016
Abstract Objective: The objective of this study was to compare the effectiveness of lercanidipine with felodipine in patients… 
2015
2015
Results: The blood pressure in group A was already lower than in group B and group C at week 4 after treatment initiation… 
2013
2013
A simple, precise and accurate method was developed and validated for analysis of Lercanidipine hydrochloride in tablets. An… 
2013
2013
In this study, the significant effect of malonic acid on enhancement of solubility of lercanidipine hydrochloride by simple… 
2012
2012
Acute vertical gaze palsy is one of the main clinical manifestations of rostral midbrain and paramedian thalamic infarctions, in… 
2012
2012
The†aim†of†the present study†was to improve lercanidipine HCl solubility and in vitro dissolution rate by preparing solid… 
2009
2009
Three simple and sensitive visible spectrophotometic methods (A-C) have been developed for the assay of Lercanidipine… 
2005
2005
Alkylation of benzene with cinnamic acid(Ⅰ) via Fridel-Crafts reaction gave 3,3-diphenyl-propanoic acid(Ⅱ),which was subsequently…